Search - tctmd.com

Displaying 561 - 580 of 988

Sort: Relevancy | Date

News Daily News

PROTECT AF: El Seguimiento a Más Largo Plazo Aclara la Situación del Dispositivo Watchman frente a la Warfarina contra la FA

Caitlin E. Cox

January 30, 2013

News Daily News

La Duración Ideal de la Terapia Antiplaquetaria Doble podría Depender del Tipo de Stent

Jason Kahn

January 22, 2013

News Daily News

Ideal Duration of Dual Antiplatelet Therapy May Depend on Stent Type

Jason Kahn

January 22, 2013

News Daily News

Unknowns Predominate in Variable Clopidogrel Response

January 16, 2013

News Daily News

Predominan Factores Desconocidos en la Respuesta Variable al Clopidogrel

January 16, 2013

Presentation

Clopidogrel Pharmacokinetics and Pharmacodynamics Vary Widely Despite Exclusion or Control of Polymorphisms, Noncompliance, Diet, Smoking, Co-medications, and Preexistent Variability in Platelet Func

Presenter: Andrew L. Frelinger

January 15, 2013

News Daily News

Prasugrel Reloading Feasible After Clopidogrel Pretreatment in ACS Patients

Yael L. Maxwell

January 13, 2013

News Daily News

Las Recargas con Prasugrel son Viables tras un Pretratamiento con Clopidogrel en Pacientes víctimas de un SCA

Yael L. Maxwell

January 13, 2013

News Daily News

Volume of Acute MI Cases Linked with Appropriate Medication Prescribing

L.A. McKeown

January 09, 2013

Presentation

Safety of Reloading Prasugrel in Addition to Clopidogrel Loading in ACS Patients Undergoing PCI

Presenter: J.P. Loh

January 09, 2013

News Daily News

Relación entre el Volumen de Casos de IAM gestionados y una Correcta Prescripción de la Medicación

L.A. McKeown

January 09, 2013

News Daily News

La Adenosina podría ser el Nexo de Unión entre el Ticagrelor y la Disnea

Caitlin E. Cox

January 09, 2013

News Daily News

Adenosine May Be the Tie That Binds Ticagrelor and Dyspnea

Caitlin E. Cox

January 09, 2013

News Daily News

Subestudio PLATO: La Ventaja del Ticagrelor Persiste tras el 1er Episodio Isquémico

January 07, 2013

News Daily News

PLATO Substudy: Ticagrelor Advantage Persists After First Ischemic Event

January 07, 2013

Presentation

Reduction in First and Recurrent Cardiovascular Events with Ticagrelor vs. Clopidogrel

Presenter: P. Kohli

January 06, 2013

News Daily News

JACC Letter: Hypothermia Therapy May Increase Stent Thrombosis Risk

L.A. McKeown

January 06, 2013

News Daily News

Carta de JACC: La Terapia Hipotérmica podría Aumentar el Riesgo de Trombosis del Stent

L.A. McKeown

January 06, 2013

News Daily News

Year in Review: Physicians Highlight the Most Important Interventional News of 2012

Caitlin E. Cox

January 02, 2013

News Daily News

TCTMD’s Top 10 Most Popular News Stories for 2012

Jason Kahn

January 02, 2013

Advertisement

PROTECT AF: El Seguimiento a Más Largo Plazo Aclara la Situación del Dispositivo Watchman frente a la Warfarina contra la FA

La Duración Ideal de la Terapia Antiplaquetaria Doble podría Depender del Tipo de Stent

Ideal Duration of Dual Antiplatelet Therapy May Depend on Stent Type

Unknowns Predominate in Variable Clopidogrel Response

Predominan Factores Desconocidos en la Respuesta Variable al Clopidogrel

Clopidogrel Pharmacokinetics and Pharmacodynamics Vary Widely Despite Exclusion or Control of Polymorphisms, Noncompliance, Diet, Smoking, Co-medications, and Preexistent Variability in Platelet Func

Prasugrel Reloading Feasible After Clopidogrel Pretreatment in ACS Patients

Las Recargas con Prasugrel son Viables tras un Pretratamiento con Clopidogrel en Pacientes víctimas de un SCA

Volume of Acute MI Cases Linked with Appropriate Medication Prescribing

Safety of Reloading Prasugrel in Addition to Clopidogrel Loading in ACS Patients Undergoing PCI

Relación entre el Volumen de Casos de IAM gestionados y una Correcta Prescripción de la Medicación

La Adenosina podría ser el Nexo de Unión entre el Ticagrelor y la Disnea

Adenosine May Be the Tie That Binds Ticagrelor and Dyspnea

Subestudio PLATO: La Ventaja del Ticagrelor Persiste tras el 1er Episodio Isquémico

PLATO Substudy: Ticagrelor Advantage Persists After First Ischemic Event

Reduction in First and Recurrent Cardiovascular Events with Ticagrelor vs. Clopidogrel

JACC Letter: Hypothermia Therapy May Increase Stent Thrombosis Risk

Carta de JACC: La Terapia Hipotérmica podría Aumentar el Riesgo de Trombosis del Stent

Year in Review: Physicians Highlight the Most Important Interventional News of 2012

TCTMD’s Top 10 Most Popular News Stories for 2012

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content